{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:06Z","timestamp":1787169846118,"version":"build-2736575974"},"reference-count":34,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCA_14746"],"award-info":[{"award-number":["INCA_14746"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In France, approximately 40% of women, including menopausal women, do not participate in cervical cancer screening. Many studies and meta-analyses have shown that self-sampling devices for high-risk human papillomavirus (HR-HPV) testing are valuable tools to increase participation. The success of self-sampling screening strategies depends on several factors, including the manner and circumstances in which the women are invited to participate. The acceptability and effectiveness of these strategies should be evaluated before further implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The primary objective is to evaluate the uptake of cervical cancer screening in under-screened women, based on a direct offer of a vaginal self-sampling device by a midwife.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>RIDECA is an interventional research project located in the South of France.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Analysis:<\/jats:title>\n                    <jats:p>Six hundred women aged 50\u201365 with no cervical smear or HR-HPV test for 3\u2009years or more will be recruited at two sites. The device will be offered to enrolled women to utilize at home and return to the Montpellier Hospital laboratory for HR-HPV testing. Completion of self-sampling by women who have accepted the device and follow-up of those with positive HR-HPV DNA tests will be monitored. During recruitment, participants will complete questionnaires on their socio-economic environment and motivational factors based on the psychosocial I-Change model. Semi-structured interviews will be conducted with a sub-group to identify barriers and levers to participation. Statistical analyses will be conducted for the full research sample and for each recruitment site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics:<\/jats:title>\n                    <jats:p>The project was approved by the Ethical Research Committee Ile de France VI and by the French Data Protection Authority.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The results will provide useful information on the effectiveness (acceptability, efficiency) of this outreach strategy and identify barriers and levers that facilitate its implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov (NCT04716127), January 20, 2021.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17455057241292693","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T11:30:09Z","timestamp":1730287809000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["An outreach strategy to increase uptake of vaginal self-sampling for cervical cancer screening in older French women: The RIDECA interventional research protocol"],"prefix":"10.1177","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0430-2148","authenticated-orcid":false,"given":"Olivier","family":"Lareyre","sequence":"first","affiliation":[{"name":"EPSYLON EA 4556, Univ. Paul Val\u00e9ry Montpellier 3, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mollevi","sequence":"additional","affiliation":[{"name":"Desbrest Institute for Epidemiology and Public Health, University of Montpellier, INSERM, Montpellier University Hospital, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-9325","authenticated-orcid":false,"given":"Guillaume","family":"Broc","sequence":"additional","affiliation":[{"name":"EPSYLON EA 4556, Univ. Paul Val\u00e9ry Montpellier 3, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Nina","family":"Caspar","sequence":"additional","affiliation":[{"name":"Departmental Council of H\u00e9rault, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergana","family":"Pehlivanska","sequence":"additional","affiliation":[{"name":"P\u00f4le de Sant\u00e9 N\u00e9os, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Boyer","sequence":"additional","affiliation":[{"name":"Medical and Social Care Center, Department of Aude, Limoux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Groc","sequence":"additional","affiliation":[{"name":"Laboratory of Solid Tumors, Montpellier University Hospital, PCCEI, University of Montpellier, INSERM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Corradi","sequence":"additional","affiliation":[{"name":"Laboratory of Solid Tumors, Montpellier University Hospital, PCCEI, University of Montpellier, INSERM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Loy-Morel","sequence":"additional","affiliation":[{"name":"Association for Breast Cancer Screening in Montpellier\u2014H\u00e9rault (AMHDCS), Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Guy","sequence":"additional","affiliation":[{"name":"Department of H\u00e9rault, Regional Cancer Screening Coordination Center\u2014Occitania, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Tricheux","sequence":"additional","affiliation":[{"name":"Medical and Social Care Center, Department of Aude, Limoux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Cousson-G\u00e9lie","sequence":"additional","affiliation":[{"name":"EPSYLON EA 4556, Univ. Paul Val\u00e9ry Montpellier 3, Montpellier, France"},{"name":"Epidaure\u2014Prevention Department of the Montpellier Cancer Institute, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Boulle","sequence":"additional","affiliation":[{"name":"Laboratory of Solid Tumors, Montpellier University Hospital, PCCEI, University of Montpellier, INSERM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"bibr1-17455057241292693","first-page":"410","volume":"23","author":"Hamers FF","year":"2019","journal-title":"Bull Epid\u00e9miolique Hebd"},{"key":"bibr2-17455057241292693","unstructured":"INCa. Panorama des cancers en France\u2014\u00e9dition 2023. Boulogne-Billancourt: INCa, 2023, 40 p. Etat des lieux et des connaissances\/Epid\u00e9miologie. https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Panorama-des-cancers-en-France-edition-2023 (accessed 2 July 2024)."},{"key":"bibr3-17455057241292693","first-page":"39","author":"Barr\u00e9 S","year":"2017","journal-title":"Bull Epid\u00e9miolique Hebd"},{"key":"bibr4-17455057241292693","first-page":"417","author":"Hamers FF","year":"2019","journal-title":"Bull Epid\u00e9miolique Hebd"},{"key":"bibr5-17455057241292693","unstructured":"Sant\u00e9 Publique France. Cancer du col de l\u2019ut\u00e9rus\u202f: la couverture du d\u00e9pistage et de la vaccination doivent progresser pour une meilleure pr\u00e9vention. https:\/\/www.santepubliquefrance.fr\/presse\/2022\/cancer-du-col-de-l-uterus-la-couverture-du-depistage-et-de-la-vaccination-doivent-progresser-pour-une-meilleure-prevention (2022, accessed 2 July 2024)."},{"key":"bibr6-17455057241292693","unstructured":"Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9. Arr\u00eat\u00e9 du 4 mai 2018 relatif \u00e0 l\u2019organisation du D\u00e9pistage Organis\u00e9 du Cancer du Col de l\u2019Ut\u00e9rus. SSAP1811940A. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000036877136 (2018, accessed 6 May 2018)."},{"key":"bibr7-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000701"},{"key":"bibr8-17455057241292693","unstructured":"Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9. Arr\u00eat\u00e9 du 30 juillet 2020 modifiant l\u2019arr\u00eat\u00e9 du 29 septembre 2006 relatif aux programmes de d\u00e9pistage organis\u00e9 des cancers et relatif \u00e0 l\u2019organisation du D\u00e9pistage Organis\u00e9 du Cancer du Col de l\u2019Ut\u00e9rus. SSAP2014049A. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000042238343 (2020, accessed 15 August 2020)."},{"key":"bibr9-17455057241292693","unstructured":"INCa. R\u00e9f\u00e9rentiel national\/D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus\/Cadre et modalit\u00e9s de recours aux autopr\u00e9l\u00e8vements vaginaux. Boulogne-Billancourt: Institut National du Cancer, 2022, 54 p. (Recommandations et r\u00e9f\u00e9rentiels). https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Referentiel-national-Depistage-du-cancer-du-col-de-l-uterus-cadre-et-modalites-de-recours-aux-autoprelevements-vaginaux"},{"key":"bibr10-17455057241292693","volume":"363","author":"Arbyn M","year":"2018","journal-title":"BMJ"},{"key":"bibr11-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.006"},{"key":"bibr12-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106900"},{"key":"bibr13-17455057241292693","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2022.33.e4"},{"key":"bibr14-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5264"},{"key":"bibr15-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1080\/03630242.2020.1831683"},{"key":"bibr16-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06977-0"},{"key":"bibr17-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586"},{"key":"bibr18-17455057241292693","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. \u00c9valuation de la recherche des papillomavirus humains (HPV) en d\u00e9pistage primaire des l\u00e9sions pr\u00e9canc\u00e9reuses et canc\u00e9reuses du col de l\u2019ut\u00e9rus et de la place du double immuno-marquage p16\/Ki67. Saint-Denis La Plaine: Haute Autorit\u00e9 de Sant\u00e9. (Recommandation en Sant\u00e9 Publique). https:\/\/www.has-sante.fr\/jcms\/c_2806160\/fr\/evaluation-de-la-recherche-des-papillomavirus-humains-hpv-en-depistage-primaire-des-lesions-precancereuses-et-cancereuses-du-col-de-l-uterus-et-de-la-place-du-double-immuno-marquage-p16\/ki67 (2019)."},{"key":"bibr19-17455057241292693","unstructured":"INCa. Conduite \u00e0 tenir devant une femme ayant une cytologie cervico-ut\u00e9rine anormale\/Th\u00e9saurus. Boulogne-Billancourt: Institut National du Cancer, 2016, 182 p. (Recommandations et r\u00e9f\u00e9rentiels). https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Conduite-a-tenir-devant-une-femme-ayant-une-cytologie-cervico-uterine-anormale-Thesaurus"},{"key":"bibr20-17455057241292693","doi-asserted-by":"publisher","DOI":"10.19080\/PBSIJ.2017.02.555585"},{"key":"bibr21-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2011-200311"},{"issue":"1","key":"bibr22-17455057241292693","first-page":"45","volume":"15","author":"Williams M","year":"2019","journal-title":"Int Manag Rev"},{"key":"bibr23-17455057241292693","unstructured":"Rohleder P, Lyons A. Qualitative research in clinical and health psychology. Houndmills, Basingstoke, Hampshire, New York, NY: Red Globe Press, 2014, 344 p."},{"key":"bibr24-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"bibr25-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00241-8"},{"key":"bibr26-17455057241292693","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva, Switzerland: World Health Organization, 2020, 56 p. https:\/\/www.who.int\/publications\/i\/item\/9789240014107"},{"issue":"465","key":"bibr27-17455057241292693","first-page":"9","volume":"2014","author":"Dalstein V","year":"2014","journal-title":"Rev Francoph Lab"},{"key":"bibr28-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.05.001"},{"key":"bibr29-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.510"},{"key":"bibr30-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1684\/bdc.2011.1388"},{"key":"bibr31-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12063"},{"key":"bibr32-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-020-01174-8"},{"key":"bibr33-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.06.001"},{"key":"bibr34-17455057241292693","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2017.04.006"}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17455057241292693","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17455057241292693","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17455057241292693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:27:55Z","timestamp":1777710475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17455057241292693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"alternative-id":["10.1177\/17455057241292693"],"URL":"https:\/\/doi.org\/10.1177\/17455057241292693","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"value":"1745-5057","type":"print"},{"value":"1745-5065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"article-number":"17455057241292693"}}